In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences
Ángel M. Cuesta, David Sánchez-Martín, Laura Sanz et al. · 2009
Read In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences by Ángel M. Cuesta, David Sánchez-Martín, Laura Sanz et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005381.txt.
Description
Cancer therapy needs agents that find tumors in the body and mark them for imaging or attack. Cuesta and colleagues built such an agent, a trivalent antibody fragment they call a trimerbody, and tested it in living animals in PLOS ONE in 2009.
The trimerbody joins a single-chain antibody fragment to a collagen-derived section that holds three arms together. Three binding arms grip tumor targets more firmly than one. In vivo tests showed the engineered fragments target tumors and support imaging, a step toward clinical scanners. Three arms cost more to make than one, so the gain must be real in the body. Not just in a dish, and the live tests here are the ones that count for that claim.
Catalog record
| CREATOR | Ángel M. Cuesta, David Sánchez-Martín, Laura Sanz et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005381